CLVSQ — Clovis Oncology Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $2.17m
- $604.23m
- $148.76m
Brief: Clovis Oncology Announces Preliminary Financial Results For Q4 And Full Year 2021
Clovis Oncology Inc reports results for the quarter ended in September - Earnings Summary
Brief: Clovis Oncology Announces Third Quarter 2021 Operating Results
Clovis Oncology Inc expected to post a loss of 48 cents a share - Earnings Preview
Brief: Clovis Oncology And ITM Announce Lutetium-177 Clinical Supply Agreement
Brief: ITM And Clovis Oncology Announce Lutetium-177 Clinical Supply Agreement
Brief: Clovis Oncology Retires Remaining 2021 Notes And Raises Additional Capital Through Its ATM Equity Offering Program
Brief: Clovis Oncology Announces Renewal Of At-The-Market Equity Offering Program
Clovis Oncology Inc reports results for the quarter ended in June - Earnings Summary
Brief: Clovis Oncology Announces Second Quarter 2021 Operating Results
Clovis Oncology Inc expected to post a loss of 56 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-BriaCell, Velodyne Lidar, Qualigen, Compass Minerals
Clovis Oncology rises, top trending on Stocktwits
Brief: Clovis Oncology's Board Increased Number Of Members Of Board From Ten To Eleven
Brief: Clovis Oncology Appoints Dr. Ronit Simantov To Its Board Of Directors
Brief: Clovis Oncology Says LuMIERE Clinical Trial Evaluating Novel Peptide-Targeted Radionuclide Therapy Fap-2286 Now Open For Enrollment
Clovis Oncology falls on $75 mln equity raise plans
Brief: Clovis Oncology Announces At-The-Market Equity Offering Program
U.S. STOCKS ON THE MOVE-Peloton, Athenex, Boeing